Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy

PURPOSE: Radiation dose escalation for prostate cancer improves biochemical control but is limited by toxicity. Magnetic resonance spectroscopic imaging (MRSI) can define dominant intraprostatic lesions (DIL). This phase I study evaluated dose escalation to MRSI-defined DIL using high-dose-rate (HDR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Contemp Brachytherapy
Main Authors: Chapman, Christopher H, Braunstein, Steve E, Pouliot, Jean, Noworolski, Susan M, Weinberg, Vivian, Cunha, Adam, Kurhanewicz, John, Gottschalk, Alexander R, Roach, Mack III, Hsu, I-Chow
Formato: Artigo
Idioma:Inglês
Publicado em: Termedia Publishing House 2018
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6052382/
https://ncbi.nlm.nih.gov/pubmed/30038638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2018.76881
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados